IFNG and cancer: CTLs secrete interferon-γ (IFN-γ) in response to cancer cells, and IFN-γ binds to IFN-γ receptors on tumor cells, thereby stimulating the JAK-STAT signaling pathway and overexpressing progressive death ligand-1 (PD-L1) [96].